(3aR,3'aR,8aS,8'a'S)-2,2'-cyclopropylidenebis[3a,8a-dihydro-8H-Indeno[1,2-d]oxazole
|
|
(3aR,3'aR,8aS,8'a'S)-2,2'-cyclopropylidenebis[3a,8a-dihydro-8H-Indeno[1,2-d]oxazole 속성
- 끓는 점
- 520.4±50.0 °C(Predicted)
- 밀도
- 1.54±0.1 g/cm3(Predicted)
- 저장 조건
- under inert gas (nitrogen or Argon) at 2-8°C
- 산도 계수 (pKa)
- 5.98±0.20(Predicted)
안전
(3aR,3'aR,8aS,8'a'S)-2,2'-cyclopropylidenebis[3a,8a-dihydro-8H-Indeno[1,2-d]oxazole C화학적 특성, 용도, 생산
(3aR,3'aR,8aS,8'a'S)-2,2'-cyclopropylidenebis[3a,8a-dihydro-8H-Indeno[1,2-d]oxazole 준비 용품 및 원자재
원자재
준비 용품
(3aR,3'aR,8aS,8'a'S)-2,2'-cyclopropylidenebis[3a,8a-dihydro-8H-Indeno[1,2-d]oxazole 공급 업체
글로벌( 32)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
Shanghai Daken Advanced Materials Co.,Ltd | +86-371-66670886 |
info@dakenam.com | China | 18751 | 58 |
Aladdin Scientific | +1-+1(833)-552-7181 |
sales@aladdinsci.com | United States | 57505 | 58 |
Shanghai Suifu Chemical Technology CO.,LTD. | 021-33738187 13341700213 |
suifuchemical@163.com | China | 584 | 58 |
Daicel Chiral Technologies (China)CO.,LTD | 021-50460086-9 15921403865 |
han_yajun@dctc.daicel.com | China | 7195 | 65 |
Tianjin Derchemist Science & Technology Co., Ltd. | 22-58627059 13920586291 |
zdcomcon@126.com | China | 3461 | 50 |
Bide Pharmatech Ltd. | 400-164-7117 13681763483 |
product02@bidepharm.com | China | 41462 | 60 |
Shanghai Chiral bio-compound co., Ltd. | 021-5068 3667/17749785980/1029026415; 17749785980 |
1029026415@qq.com | China | 3013 | 58 |
Zhengzhou Kingorgchem Chemical Technology Co., Ltd.gy Co., Ltd. | 0371-65511006 18625597674 |
sales@kingorgchem.com | China | 954 | 55 |
Zhengzhou Huiju Chemical Co., Ltd. | 0371-55900031 18137872243 |
2853979815@qq.com | China | 10007 | 55 |
LaaJoo | 021-60702684 18516024827 |
huang.jiayi@sinocompound.com | China | 2409 | 58 |
(3aR,3'aR,8aS,8'a'S)-2,2'-cyclopropylidenebis[3a,8a-dihydro-8H-Indeno[1,2-d]oxazole 관련 검색:
INDEX NAME NOT YET ASSIGNED
8H-Indeno[1,2-d]oxazole, 2,2'-[2-[4-(1,1-dimethylethyl)phenyl]-1-[[4-(1,1-dimethylethyl)phenyl]methyl]ethylidene]bis[3a,8a-dihydro-, (3aR,3'aR,8aS,8'aS)-
(3aR,3'aR,8aS,8'aS)-2,2'-Cyclobutylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole]
(3aR,3'aR,8aS,8'aS)-2,2'-Cyclopentylidenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole]
(+)-2,2'-METHYLENEBIS[(3AR,8AS)-3A,8A-DIHYDRO-8H-INDENO[1,2-D]OXAZOLE]
(3aR,3a'R,8aS,8a'S)-2,2'-(1,3-diphenylpropane-2,2-diyl)bis(3a,8a-dihydro-8H-indeno[1,2-d]oxazole)
(-)-2,2'-METHYLENEBIS[(3AS,8AR)-3A,8A-DIHYDRO-8H-INDENO[1,2-D]OXAZOLE]
(3aS,3'aS,8aR,8'a'R)-2,2'-cyclopropylidenebis[3a,8a-dihydro-8H-Indeno[1,2-d]oxazole
(3aS,3a'S,8aR,8a'R)-2,2'-(1,3-Diphenylpropane-2,2-diyl)bis(8,8a-dihydro-3aH-indeno[1,2-d]oxazole)
(3aS,3'aS,8aR,8'aR)-2,2'-Cyclopentylidenebis[3a,8a-dihydr
o-8H-indeno[1,2-d]oxazole]